Literature DB >> 1577770

The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern.

J Zheng1, F Schödel, D L Peterson.   

Abstract

A set of wild-type and mutant human, woodchuck, and duck hepatitis viral core proteins have been prepared and used to study the free thiol groups and the disulfide bonding pattern present within the core particle. Human (HBcAg) and woodchuck (WHcAg) core proteins contain 4 cysteine residues, whereas duck (DHcAg) core protein contains a single cysteine residue. Each of the cysteines of HBcAg has been eliminated, either singly or in combinations, by a two-step mutagenesis procedure. All of the proteins were shown to have very similar physical and immunochemical properties. All assemble into essentially identical core particle structures. Therefore disulfide bonds are not essential for core particle formation. No intra-chain disulfide bonds occur. Cys107 is a free thiol buried within the particle structure, whereas Cys48 is present partly as a free sulfhydryl which is exposed at the surface of the particle. Cys61 is always and Cys48 is partly involved in interchain disulfide bonds with the identical residues of another monomer, whereas Cys183 is always involved in a disulfide bond with the Cys183 of a different monomer. WHcAg has the same pattern of bonding, whereas DHcAg lacks any disulfide bonds, and the single free sulfhydryl, Cys153 which is equivalent to Cys107 of HBcAg, is buried.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Hepatitis B virus morphogenesis.

Authors:  Volker Bruss
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.

Authors:  An Li; Quan Yuan; Zhiyin Huang; Jian Fan; Ruyi Guo; Bin Lou; Qin Zheng; Shengxiang Ge; Yixin Chen; Zhijun Su; Anthony E T Yeo; Yu Chen; Jun Zhang; Ningshao Xia
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

Review 3.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

4.  A protease-sensitive hinge linking the two domains of the hepatitis B virus core protein is exposed on the viral capsid surface.

Authors:  M Seifer; D N Standring
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA.

Authors:  A Zlotnick; N Cheng; S J Stahl; J F Conway; A C Steven; P T Wingfield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

6.  The method of noncovalent in vitro binding of target proteins to virus-like nanoparticles formed by core antigen of hepatitis B virus.

Authors:  E A Blokhina; V V Kupriyanov; N V Ravin; K G Skryabin
Journal:  Dokl Biochem Biophys       Date:  2013-03-13       Impact factor: 0.788

7.  Mapping of homologous interaction sites in the hepatitis B virus core protein.

Authors:  S König; G Beterams; M Nassal
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein.

Authors:  S Le Pogam; T T Yuan; G K Sahu; S Chatterjee; C Shih
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Antibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivo.

Authors:  S Gantt; C Persson; K Rose; A J Birkett; R Abagyan; V Nussenzweig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 10.  Use of hepadnavirus core proteins as vaccine platforms.

Authors:  David C Whitacre; Byung O Lee; David R Milich
Journal:  Expert Rev Vaccines       Date:  2009-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.